Investigational Site Number : 724008

Seville 41071

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Hematological Malignancy, Multiple Sclerosis Relapse, Squamous Cell Lung Cancer

Studies at this site

• Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies — Completed
• Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed
• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early